GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Clinical Laserthermia Systems AB (OSTO:CLS B) » Definitions » Research & Development

Clinical Laserthermia Systems AB (OSTO:CLS B) Research & Development : kr0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Clinical Laserthermia Systems AB Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Clinical Laserthermia Systems AB's Research & Development for the three months ended in Mar. 2024 was kr0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.00 Mil.

Clinical Laserthermia Systems AB Research & Development Historical Data

The historical data trend for Clinical Laserthermia Systems AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clinical Laserthermia Systems AB Research & Development Chart

Clinical Laserthermia Systems AB Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Clinical Laserthermia Systems AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Clinical Laserthermia Systems AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clinical Laserthermia Systems AB  (OSTO:CLS B) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Clinical Laserthermia Systems AB Research & Development Related Terms

Thank you for viewing the detailed overview of Clinical Laserthermia Systems AB's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Clinical Laserthermia Systems AB (OSTO:CLS B) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Clinical Laserthermia Systems AB (OSTO:CLS B) » Definitions » Research & Development
Comparable Companies
OSTO:NOSA OSTO:IRRAS OSTO:DIGN XSAT:REDS XSAT:PHI NGM:MCLR OSTO:SCIB OSTO:ACARIX OSTO:ICO OSTO:ARCOMA ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
LS6:Germany
Address
Scheelevagen 2, Medicon village, Lund, SWE, 223 81
Website
http://www.clinicallaser.se
Clinical Laserthermia Systems AB develops and sells single-use products used during each treatment procedure of treatment of solid tumors cancers. Its products include Thermal Therapy System, Mobile Laser Unit, Laser Applicator Non-cooled and Tissue Temp Probe.

Clinical Laserthermia Systems AB (OSTO:CLS B) Headlines

No Headlines